Last updated: 18 June 2019 at 4:34am EST

John E Paproski Net Worth




The estimated Net Worth of John E Paproski is at least $27.4 Million dollars as of 25 November 2015. John Paproski owns over 17,560 units of West Pharmaceutical Services stock worth over $26,560,843 and over the last 17 years John sold WST stock worth over $878,930.

John Paproski WST stock SEC Form 4 insiders trading

John has made over 7 trades of the West Pharmaceutical Services stock since 2011, according to the Form 4 filled with the SEC. Most recently John exercised 17,560 units of WST stock worth $394,924 on 25 November 2015.

The largest trade John's ever made was exercising 17,560 units of West Pharmaceutical Services stock on 25 November 2015 worth over $394,924. On average, John trades about 1,649 units every 38 days since 2008. As of 25 November 2015 John still owns at least 87,848 units of West Pharmaceutical Services stock.

You can see the complete history of John Paproski stock trades at the bottom of the page.



What's John Paproski's mailing address?

John's mailing address filed with the SEC is 101 GORDON DRIVE, , LIONVILLE, PA, 19341.

Insiders trading at West Pharmaceutical Services

Over the last 19 years, insiders at West Pharmaceutical Services have traded over $32,829,857 worth of West Pharmaceutical Services stock and bought 19,924 units worth $1,139,950 . The most active insiders traders include Robert F Friel, Paolo Pucci, and Douglas A Michels. On average, West Pharmaceutical Services executives and independent directors trade stock every 40 days with the average trade being worth of $4,786,805. The most recent stock trade was executed by Charles Witherspoon on 19 August 2024, trading 1,029 units of WST stock currently worth $308,700.



What does West Pharmaceutical Services do?

west works side-by-side with healthcare partners from concept to the patient, designing and manufacturing packaging and delivery systems that promote efficiency, reliability and safety. west leads the way with cutting-edge technologies and quality systems, a thorough understanding of global regulatory compliance, and an unmatched knowledge of relevant pharmaceutical product testing, development and packaging. west supports customers from sales, manufacturing, and research and development locations in north and south america, europe, asia and australia.



What does West Pharmaceutical Services's logo look like?

West Pharmaceutical Services, Inc. logo

Complete history of John Paproski stock trades at West Pharmaceutical Services

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
25 Nov 2015 John E Paproski
Vice President-Innovations
Option 17,560 $22.49 $394,924
25 Nov 2015
87,848
24 Feb 2015 John E Paproski
Vice President-Innovations
Option 9,282 $16.29 $151,204
24 Feb 2015
78,824
7 Aug 2014 John E Paproski
Vice President-Innovations
Option 14,000 $12.77 $178,780
7 Aug 2014
68,847
24 Feb 2014 John E Paproski
Vice President-Innovations
Sale 8,500 $47.48 $403,580
24 Feb 2014
54,590
14 Aug 2013 John E Paproski
Vice President-Innovations
Sale 6,011 $79.08 $475,350
14 Aug 2013
655
29 Nov 2012 John E Paproski
Vice President-Innovations
Option 8,200 $19.37 $158,834
29 Nov 2012
35,201
10 May 2011 John E Paproski
Vice President-Innovations
Option 9,000 $14.41 $129,690
10 May 2011
34,086


West Pharmaceutical Services executives and stock owners

West Pharmaceutical Services executives and other stock owners filed with the SEC include: